ENHANCE Transcarotid Peripheral Access Kit: cost and payments to doctors
What Medicare Part D paid pharmacies for ENHANCE Transcarotid Peripheral Access Kit, and the payments that named it as the associated device or medical supply under the Sunshine Act for program years 2019–2025.
Was your doctor paid by Silk Road Medical, Inc.?
Silk Road Medical, Inc. reported the most payments naming ENHANCE Transcarotid Peripheral Access Kit. Search your clinician to see whether they are among them — and what else they were paid for.
Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.
- Total reported
- $6.5M
- Providers
- 3,873
- Transactions
- 17,589
- Average per transaction
- $372
The per-transaction average — $372 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3,873 providers the average total is $1,689, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Silk Road Medical, Inc. | $6,529,954 | 99.8% |
| Boston Scientific | $10,139 | 0.2% |
Other products from Silk Road Medical, Inc.
The company that reported the most payments naming ENHANCE Transcarotid Peripheral Access Kit also reports against these.
- ENROUTE Transcarotid Neuroprotection System$17,236,154
- ENROUTE Transcarotid Stent$10,000,756
- ENROUTE Transcarotid Stent System$4,440,866
- ENROUTE 0.014 Guidewire$4,440,866
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$2,794,532
- ENROUTE .014 Guidewire$2,089,088